Key figures
- Revenues of almost 2,318 million euros in 2017, more than 62% of which was achieved outside France
- 13,500 employees worldwide
-
- 14% of our pharmaceutical turnover is reinvested in Research and Development
Annual report
The Activity and Sustainable Development Report presents our activities, our values, our figures.
